Hologic Management Shakeup Includes New CEO, Board Members | GenomeWeb

NEW YORK (GenomeWeb News) – Hologic today named former Stryker executive Stephen MacMillan as its president and CEO, replacing Jack Cumming less than five months after Cumming returned for a second stint as head of the company.

MacMillan also was named to Hologic's board. Separately, the company also named Jonathan Christodoro and Samuel Merksamer, both of whom are managing directors at Icahn Capital, to its board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.